IDEXX Laboratories

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade IDEXX Laboratories 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About IDXX

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. 

CEO
Jonathan J. Mazelsky
CEOJonathan J. Mazelsky
Employees
11,000
Employees11,000
Headquarters
Westbrook, Maine
HeadquartersWestbrook, Maine
Founded
1983
Founded1983
Employees
11,000
Employees11,000

IDXX Key Statistics

Market cap
46.83B
Market cap46.83B
Price-Earnings ratio
43.59
Price-Earnings ratio43.59
Dividend yield
Dividend yield
Average volume
469.62K
Average volume469.62K
High today
$594.51
High today$594.51
Low today
$580.47
Low today$580.47
Open price
$582.48
Open price$582.48
Volume
493.54K
Volume493.54K
52 Week high
$769.98
52 Week high$769.98
52 Week low
$402.85
52 Week low$402.85

Stock Snapshot

The current IDEXX Laboratories(IDXX) stock price is $588.83, with a market capitalization of 46.83B. The stock trades at a price-to-earnings (P/E) ratio of 43.59.

As of 2026-04-17, IDEXX Laboratories(IDXX) stock has fluctuated between $580.47 and $594.51. The current price stands at $588.83, placing the stock +1.4% above today's low and -1.0% off the high.

The IDEXX Laboratories(IDXX)'s current trading volume is 493.54K, compared to an average daily volume of 469.62K.

In the last year, IDEXX Laboratories(IDXX) shares hit a 52-week high of $769.98 and a 52-week low of $402.85.

In the last year, IDEXX Laboratories(IDXX) shares hit a 52-week high of $769.98 and a 52-week low of $402.85.

IDXX News

Simply Wall St 2d
Is It Too Late To Consider IDEXX Laboratories After Its 44% One Year Surge?

Wondering if IDEXX Laboratories at around US$580.76 a share still offers value, or if the best gains are already behind it? This article walks through what that...

Is It Too Late To Consider IDEXX Laboratories After Its 44% One Year Surge?
TipRanks 3d
Idexx Laboratories initiated with a Neutral at Citi

Citi analyst Daniel Grosslight initiated coverage of Idexx Laboratories (IDXX) with a Neutral rating and $650 price target The firm launched the animal health a...

Simply Wall St 6d
The Bull Case For IDEXX Laboratories Could Change Following UK Launch Of Canine Cancer Dx Panel – Learn Why

On 1 April 2026, IDEXX Laboratories launched the IDEXX Cancer Dx Panel in the UK, offering a blood-based test for early detection of lymphoma in at-risk dogs vi...

The Bull Case For IDEXX Laboratories Could Change Following UK Launch Of Canine Cancer Dx Panel – Learn Why

Analyst ratings

67%

of 18 ratings
Buy
66.7%
Hold
27.8%
Sell
5.6%

More IDXX News

Simply Wall St 7d
A Look At IDEXX Laboratories Valuation After Its Cancer Dx Panel Expansion In The United Kingdom

IDEXX Laboratories (IDXX) recently extended its Cancer Dx Panel to veterinary practices in the United Kingdom, giving investors fresh product news to weigh alon...

A Look At IDEXX Laboratories Valuation After Its Cancer Dx Panel Expansion In The United Kingdom

People also own

Based on the portfolios of people who own IDXX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.